Combination of thrombopoietin mimetic and cyclosporin a (DrugBank: Cyclosporin, Cyclosporin A, Thrombopoietin)
3 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
47 | Buerger disease | 0 |
60 | Aplastic anemia | 1 |
63 | Idiopathic thrombocytopenic purpura | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03896971 (ClinicalTrials.gov) | May 15, 2019 | 21/3/2019 | Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic Anaemia | Treatment With Thrombopoietin Mimetic Plus Immunosuppressive Therapy in Egyptian Patients With Aplastic Anaemia | Aplastic Anemia | Drug: Combination of thrombopoietin mimetic and cyclosporin A | Safaa AA Khaled | Assiut University | Recruiting | 16 Years | 65 Years | All | 60 | Phase 4 | Egypt |